Eran Ovadya, Chief Financial Officer of NurExone stated, "The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.

"The Evrysdi tablet combines established efficacy with convenience, providing an additional flexible option for SMA management." The approval of the Evrysdi tablet was based on the results of a ...

Safety Study of Stem Cell-derived Transplant Includes Subacute and Chronic SCI Patients. CARLSBAD, CA, USA I 11, 2025 I Lineage Cell Therapeutics, Inc. (NYSE American and ...

Three people with a muscle-destroying disease destined to worsen got a little stronger — able to stand and walk more easily — ...

Medically reviewed by Amy Kwan, PT Your latissimus dorsi (your "lats") is a broad, flat, triangle-shaped muscle that spans ...